How omega-3 fish oil transforms heart health and beyond in 2026

How omega-3 fish oil transforms heart health and beyond in 2026

Emily Haynes
Emily Haynes•
• 2 Min.
A pile of vibrant orange fish oil capsules on a crisp white plate.

How omega-3 fish oil transforms heart health and beyond in 2026

Fish oil, widely known as omega-3, remains one of the most popular dietary supplements worldwide. Derived from oily fish, it contains essential polyunsaturated fatty acids—EPA and DHA—which have long been linked to heart health and broader wellness benefits.

Scientific interest in fish oil grew sharply in the 1970s after researchers uncovered the heart-protective effects of omega-3 fatty acids. These compounds help cell membranes stay fluid and flexible, supporting key bodily functions. Over time, studies confirmed their role in lowering triglycerides, a type of fat in the blood, with higher doses (over 2 grams daily) showing the strongest impact.

A 2023 study further reinforced this connection, finding a near-linear relationship between fish oil dosage and improvements in heart-related risk factors. Beyond cardiovascular benefits, omega-3s also offer mild anti-inflammatory effects, easing joint pain and stiffness in conditions like inflammatory arthritis.

By late 2023, the FDA approved a high-dose prescription omega-3 (Vascepa in the US, later branded Vazkepa in Europe) based on clinical trials like REDUCE-IT, which demonstrated reduced cardiovascular risks. The European Medicines Agency followed in May 2024, and by early 2026, the drug gained reimbursement approvals in several EU countries, including Germany, the UK, and France. Availability expanded across Canada and Japan, though adoption remains uneven due to cost and competition from generic alternatives.

For most users, fish oil is safe, with minor side effects like a fishy aftertaste, mild nausea, or diarrhoea. Despite this, its reputation persists as a supplement for heart protection, mood support, and general inflammation reduction.

High-dose prescription omega-3s like Vazkepa are now part of cardiovascular treatment guidelines in multiple countries. Their growing medical recognition contrasts with the supplement's long-standing popularity, backed by decades of research. While access varies, the evidence continues to highlight omega-3s as a key player in heart and joint health.